292 related articles for article (PubMed ID: 22982426)
1. Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis.
Adibi M; Hornberger B; Bhat D; Raj G; Roehrborn CG; Lotan Y
J Urol; 2013 Feb; 189(2):535-40. PubMed ID: 22982426
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis.
Adibi M; Pearle MS; Lotan Y
BJU Int; 2012 Jul; 110(2 Pt 2):E86-91. PubMed ID: 22115356
[TBL] [Abstract][Full Text] [Related]
3. Reduction in hospital admissions with the addition of prophylactic intramuscular ceftriaxone before transrectal ultrasonography-guided prostate biopsies.
Luong B; Danforth T; Visnjevac O; Suraf M; Duff M; Chevli KK
Urology; 2015 Mar; 85(3):511-6. PubMed ID: 25596154
[TBL] [Abstract][Full Text] [Related]
4. Infection related hospitalizations after prostate biopsy in a statewide quality improvement collaborative.
Womble PR; Dixon MW; Linsell SM; Ye Z; Montie JE; Lane BR; Miller DC; Burks FN;
J Urol; 2014 Jun; 191(6):1787-92. PubMed ID: 24345442
[TBL] [Abstract][Full Text] [Related]
5. Infection-related hospital admissions after transrectal biopsy of the prostate.
Sanders A; Buchan N
ANZ J Surg; 2013 Apr; 83(4):246-8. PubMed ID: 23346881
[TBL] [Abstract][Full Text] [Related]
6. Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care.
Taylor AK; Zembower TR; Nadler RB; Scheetz MH; Cashy JP; Bowen D; Murphy AB; Dielubanza E; Schaeffer AJ
J Urol; 2012 Apr; 187(4):1275-9. PubMed ID: 22341272
[TBL] [Abstract][Full Text] [Related]
7. The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis?
Feliciano J; Teper E; Ferrandino M; Macchia RJ; Blank W; Grunberger I; Colon I
J Urol; 2008 Mar; 179(3):952-5; discussion 955. PubMed ID: 18207185
[TBL] [Abstract][Full Text] [Related]
8. Comparative Effectiveness of Single versus Combination Antibiotic Prophylaxis for Infections after Transrectal Prostate Biopsy.
Marino K; Parlee A; Orlando R; Lerner L; Strymish J; Gupta K
Antimicrob Agents Chemother; 2015 Dec; 59(12):7273-5. PubMed ID: 26369958
[TBL] [Abstract][Full Text] [Related]
9. Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis?
Carignan A; Roussy JF; Lapointe V; Valiquette L; Sabbagh R; Pépin J
Eur Urol; 2012 Sep; 62(3):453-9. PubMed ID: 22575912
[TBL] [Abstract][Full Text] [Related]
10. Clinical importance of the antibiotic regimen in transrectal ultrasound-guided biopsy: quinolone versus cephalosporin.
Lee JK; Lee S; Hong SK; Byun SS; Lee SE
BMC Urol; 2016 Aug; 16(1):51. PubMed ID: 27557527
[TBL] [Abstract][Full Text] [Related]
11. A Statewide Intervention to Reduce Hospitalizations after Prostate Biopsy.
Womble PR; Linsell SM; Gao Y; Ye Z; Montie JE; Gandhi TN; Lane BR; Burks FN; Miller DC;
J Urol; 2015 Aug; 194(2):403-9. PubMed ID: 25896556
[TBL] [Abstract][Full Text] [Related]
12. Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy.
Liss MA; Taylor SA; Batura D; Steensels D; Chayakulkeeree M; Soenens C; Rao GG; Dash A; Park S; Patel N; Woo J; McDonald M; Nseyo U; Banapour P; Unterberg S; Ahlering TE; Van Poppel H; Sakamoto K; Fierer J; Black PC
J Urol; 2014 Dec; 192(6):1673-8. PubMed ID: 24928266
[TBL] [Abstract][Full Text] [Related]
13. Febrile reactions after transrectal ultrasound-guided prostatic biopsy: a retrospective study.
Hedelin H; Claesson BE; Wilpart A
Scand J Urol Nephrol; 2011 Dec; 45(6):393-6. PubMed ID: 21679017
[TBL] [Abstract][Full Text] [Related]
14. For Single Dosing, Levofloxacin Is Superior to Ciprofloxacin When Combined With an Aminoglycoside in Preventing Severe Infections After Prostate Biopsy.
Unnikrishnan R; El-Shafei A; Klein EA; Jones JS; Kartha G; Goldman HB
Urology; 2015 Jun; 85(6):1241-6. PubMed ID: 25863835
[TBL] [Abstract][Full Text] [Related]
15. Effect of Augmented Antimicrobial Prophylaxis and Rectal Swab Culture-guided Targeted Prophylaxis on the Risk of Sepsis Following Transrectal Prostate Biopsy.
Hadjipavlou M; Eragat M; Kenny C; Pantelidou M; Mulhem W; Wood C; Dall'Antonia M; Hammadeh MY
Eur Urol Focus; 2020 Jan; 6(1):95-101. PubMed ID: 31928632
[TBL] [Abstract][Full Text] [Related]
16. "Targeted" prophylaxis: Impact of rectal swab culture-directed prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy.
Singh P; Kumar A; Yadav S; Prakash L; Nayak B; Kumar R; Kapil A; Dogra PN
Investig Clin Urol; 2017 Sep; 58(5):365-370. PubMed ID: 28868509
[TBL] [Abstract][Full Text] [Related]
17. Rectal swab culture-directed antimicrobial prophylaxis for prostate biopsy and risk of postprocedure infection: a cohort study.
Dai J; Leone A; Mermel L; Hwang K; Pareek G; Schiff S; Golijanin D; Renzulli JF
Urology; 2015 Jan; 85(1):8-14. PubMed ID: 25458193
[TBL] [Abstract][Full Text] [Related]
18. Comparative Effectiveness of Targeted vs Empirical Antibiotic Prophylaxis to Prevent Sepsis from Transrectal Prostate Biopsy: A Retrospective Analysis.
Liss MA; Kim W; Moskowitz D; Szabo RJ
J Urol; 2015 Aug; 194(2):397-402. PubMed ID: 25846415
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic prophylaxis for transrectal prostate biopsy-a new strategy.
Antsupova V; Nørgaard N; Bisbjerg R; Nygaard Jensen J; Boel J; Jarløv JO; Arpi M
J Antimicrob Chemother; 2014 Dec; 69(12):3372-8. PubMed ID: 25114164
[TBL] [Abstract][Full Text] [Related]
20. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy.
Nam RK; Saskin R; Lee Y; Liu Y; Law C; Klotz LH; Loblaw DA; Trachtenberg J; Stanimirovic A; Simor AE; Seth A; Urbach DR; Narod SA
J Urol; 2010 Mar; 183(3):963-8. PubMed ID: 20089283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
